甲亢性肝损伤在临床上比较常见,有学者报道其发生率在46%～88%[1]。甲亢性肝损伤的治疗原则以控制甲亢为主,辅以保肝治疗,甲亢的治疗又以药物为主,丙硫氧嘧啶(PTU)为首选药物[2]。PTU治疗的不良反应包括肝损害、白细胞减少等。肝损伤和中性粒细胞减少是影响甲亢治疗方案选择和 Hyperthyroidism liver injury is more common in clinical practice, some scholars have reported that the incidence of 46% to 88% [1]. Hyperthyroidism liver injury treatment principle to control hyperthyroidism, supplemented by liver protection, hyperthyroidism and drug-based treatment, propylthiouracil (PTU) as the drug of choice [2]. Adverse reactions PTU treatment include liver damage, leukopenia and so on. Liver damage and neutropenia are the treatment options that affect hyperthyroidism